| CT (LUX) RESPONSIBLE GLOBAL EMERGING MARKETS EQUITY A USD DIS | RVI EMERGENTES | 32,687409 | 19/11/2026 | 15,41% | 45,11% | *** |
| FIDELITY FUNDS-EUROPE EQUITY ESG A-ACC-EUR | RVI EUROPA | 25,090000 | 19/11/2026 | 15,41% | 50,24% | *** |
| GOLDMAN SACHS GLOBAL SMALL CAP CORE EQUITY PORTFOLIO R (CLOSE) EUR CAP | RVI GLOBAL SMALL/MID CAP | 13,180000 | 19/11/2026 | 15,41% | · | ND |
| MFS MERIDIAN CONTRARIAN CAPITAL FUND IH1-EUR | RVI GLOBAL VALOR | 148,170000 | 19/11/2026 | 15,41% | · | ND |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND BI-USD | RVI EMERGENTES | 199,192140 | 19/11/2026 | 15,41% | 58,73% | **** |
| NORDEA 2 - BETAPLUS ENHANCED GLOBAL SUSTAINABLE EQUITY FUND BI2-EUR | RVI GLOBAL | 237,155300 | 18/11/2026 | 15,41% | · | ND |
| SCHRODER ISF ASIAN OPPORTUNITIES A ACC NOK | RVI ASIA EX-JAPÓN | 28,199211 | 19/11/2026 | 15,41% | 55,77% | *** |
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI A | RVI SALUD | 39,129780 | 19/11/2026 | 15,41% | 25,99% | ** |
| UBS S&P 500 SF UCITS ETF USD ACC | RVI USA | 130,874271 | 18/11/2026 | 15,41% | · | ND |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND C EUR CAP | RVI BIOTECNOLOGÍA | 11,646000 | 18/11/2026 | 15,40% | 62,38% | ** |